Literature DB >> 7495731

Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4.

F Rousset1, S Peyrol, E Garcia, N Vezzio, M Andujar, J A Grimaud, J Banchereau.   

Abstract

We compared the effects of IL-10 and IL-4 on the functions of B lymphocytes triggered through their CD40. During the initial phase, IL-10 was as potent as IL-4 in inducing the expansion of viable B cells. Then, cellular expansion slowed down and after approximately 3 weeks the number of B cells started to decline. While the combination of IL-10 and IL-4 was synergistic during the first 2 weeks of culture, B cell recovery declined after 3 weeks, indicating that IL-10 prevails over IL-4. Those effects were not restricted to a specific B cell subset as both sIgD+ B cells and sIgD- B cells behaved in a similar way, though the latter population responded with a slightly accelerated kinetic. Inverted microscope examination and scanning electron microscopy showed that in response to IL-10, CD40-activated B cell cultures were heterogeneous with loose aggregates of cells as well as free floating large ovoid cells. In contrast, in the presence of IL-4, CD40-activated B cell cultures were essentially composed of tight cell clumps. IL-10 progressively induced all B cells to differentiate into non-replicating cells with intracytoplasmic Ig that secreted Ig at a high rate. Cytologic analysis indicated that IL-10 cultured cells display a basophilic cytoplasm with an arcoplasm and a low nucleus/cytoplasm ratio. Transmission electron microscopy demonstrated that when IL-10 was added to the culture, B cells displayed structures for excretion with extended endoplasmic reticulum and dilated cisternae containing paracrystalline structures, typical of plasmablasts cells. Taken together, these results indicate that IL-10 acts as a plasma cell differentiation factor for CD40-activated B cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7495731     DOI: 10.1093/intimm/7.8.1243

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  29 in total

1.  Determination of the frequency of HLA antibody secreting B-lymphocytes in alloantigen sensitized individuals.

Authors:  A Mulder; M J Kardol; J Kamp; C Uit Het Broek; G M Schreuder; I I Doxiadis; F H Claas
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages.

Authors:  Fatemeh Momen-Heravi; Shashi Bala; Terence Bukong; Gyongyi Szabo
Journal:  Nanomedicine       Date:  2014-03-29       Impact factor: 5.307

3.  The Role of the Transcription Factor Ets1 in Lupus and Other Autoimmune Diseases.

Authors:  Lee Ann Garrett-Sinha; Alyssa Kearly; Anne B Satterthwaite
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

4.  Effect of B-cell receptor engagement on CD40-stimulated B cells.

Authors:  B M Schilizzi; R Boonstra; T H The; L F de Leij
Journal:  Immunology       Date:  1997-11       Impact factor: 7.397

5.  Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.

Authors:  Jesse D Deere; W L William Chang; Andradi Villalobos; Kimberli A Schmidt; Ashlesha Deshpande; Luis D Castillo; Joseph Fike; Mark R Walter; Peter A Barry; Dennis J Hartigan-O'Connor
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-12       Impact factor: 11.205

6.  Establishment of long-term CD154-dependent porcine B-cell cultures.

Authors:  H Takamatsu; J K Andersen; M S Denyer; R M Parkhouse
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

7.  Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules.

Authors:  Vito Racanelli; Maria Antonia Frassanito; Patrizia Leone; Maria Galiano; Valli De Re; Franco Silvestris; Franco Dammacco
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 8.  Targeting IL-10 Family Cytokines for the Treatment of Human Diseases.

Authors:  Xiaoting Wang; Kit Wong; Wenjun Ouyang; Sascha Rutz
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-02-01       Impact factor: 10.005

Review 9.  Cytokines in Sjögren's syndrome.

Authors:  N Roescher; P P Tak; G G Illei
Journal:  Oral Dis       Date:  2009-06-10       Impact factor: 3.511

10.  Genome-wide analysis of immune activation in human T and B cells reveals distinct classes of alternatively spliced genes.

Authors:  Yevgeniy A Grigoryev; Sunil M Kurian; Aleksey A Nakorchevskiy; John P Burke; Daniel Campbell; Steve R Head; Jun Deng; Aaron B Kantor; John R Yates; Daniel R Salomon
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.